Covid-19: Pfizer to file for emergency authorization for its vaccine, reaches safety milestone
The US drugmaker is now set to file for an emergency use authorization from the US Food and Drug Administration.
The US drugmaker is now set to file for an emergency use authorization from the US Food and Drug Administration.
The EU is making plans to buy 300 million doses of BioNTech-Pfizer’s COVID-19 vaccine.
On a W/W performance review, the Spanish Stock index, IBEX up 13.13%, and French Stock In CAC 40 up 12.59%
At about 10.05 am Nigerian time on Tuesday, November 10, Gold futures were up 1.69% at $1885.60.
Gold futures traded at $1,890/ounce, losing over 3% in value after trading as high as $1966/ounce on Monday morning.
Pfizer Inc could have a COVID-19 vaccine available in the world's largest economy by the end of 2020.
Pfizer Inc. has disclosed that its Covid-19 vaccine could be available for use in the U.S. by late November.
Moderna has already begun experimental testing on humans.
WHO has been working to expand access to potential vaccines and scale up production capacity.
UK now has 3 different types of vaccine under development with a total of 230 million doses.